Bionik Laboratories Corp.

47 articles with Bionik Laboratories Corp.

• BIONIK Laboratories to Participate at MEDICA, a Leading International Trade Show for the Medical Industry

  11/11/2021

  BIONIK Laboratories Corp. (OTCQB: BNKL) (“BIONIK” or the “Company”), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced its participation in the MEDICA Trade Show in Dusseldorf, Germany from November 15–18, 2021.

• BIONIK Laboratories Announces Commercial Team Addition With Newly Hired Regional Sales Director, Tony Bellofatto

  10/28/2021

  BIONIK Laboratories Corp. today announced the hiring of a new Regional Sales Director, Tony Bellofatto.

• BIONIK Laboratories Reports a 72% Increase in Patient Sessions on its InMotion® Robotic Devices Since Launch of InMotion Connect™ Platform

  9/22/2021

  BIONIK Laboratories Corp . today announced hospitals and other healthcare facilities utilizing InMotion Connect™ have seen a 72% increase in patient sessions on InMotion® robotic devices nationwide since the launch of the proprietary data platform last year.

• BIONIK Laboratories Reports Fiscal 2022 Q1 Financial Results

  8/12/2021

  BIONIK Laboratories Corp . today reported financial results for its first quarter of fiscal year 2022, for the period ended June 30, 2021.

• BIONIK Laboratories Announces Resignation of CEO, Names Interim CEO

  7/19/2021

  BIONIK Laboratories Corp. today has announced that Chief Executive Officer and Board Member Dr. Eric Dusseux has resigned as Chief Executive Officer and stepped down from the board

• BIONIK Laboratories Announces Fiscal 2021 Q2 Financial Results

  11/12/2020

  BIONIK Laboratories Corp . (OTCQB: BNKL) , a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced financial results for its second quarter of fiscal year 2021, ending September 30, 2020. Financial highlights for the second quarter of fiscal 2021 and recent weeks include:

• BIONIK Laboratories Announces Sale of New InMotion® ARM/HAND Robotic Device to VA Rehabilitation Research & Development’s Center for Neurorestoration and Neurotechnology

  9/30/2020

  BIONIK Laboratories Announces Sale of New InMotion ® ARM/HAND Robotic Device to VA Rehabilitation Research & Development’s Center for Neurorestoration and Neurotechnology VA-funded center purchases second InMotion ® ARM/HAND interactive therapy system to test new approaches for restoring physical function of veterans with neurologic disease or injury TORONTO & BOSTON--( BUSINESS WIRE )-- BIONIK Laboratories Corp . (OTCQB:BNKL) ("BIONIK" or

• BIONIK Laboratories Announces Fiscal 2020 Financial Results

  6/30/2020

  BIONIK Laboratories Corp . (OTCQB:BNKL) ("BIONIK"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced financial results for the fiscal year ended March 31, 2020. Financial highlights for the fiscal year 2020 and recent weeks include : Reported sales of $2,153,354 for

• BIONIK Laboratories Donates InMotion® Robotic System to Einstein Healthcare Network’s MossRehab for Use in New COVID-19 Rehab Unit

  5/12/2020

  MossRehab, led by renowned Dr. Alberto Esquenazi, utilizing BIONIK’s robotic therapy system in new CORE+ Unit to treat patients infected with or recovering from COVID-19 TORONTO & BOSTON--( BUSINESS WIRE )-- BIONIK Laboratories Corp . (OTCQB:BNKL) ("BIONIK"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced it h

• BIONIK Laboratories Announces Third Quarter Fiscal 2020 Financial Results

  2/14/2020

  BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced financial results for the third quarter of fiscal year 2020, ended December 31, 2019.

• BIONIK Laboratories Announces Regulatory Approval and First Sale of its InMotion® ARM Robotic Technology by its Exclusive Distributor in South Korea

  1/30/2020

  BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced it has received regulatory approval in South Korea, and that its exclusive distributor Curexo secured the first sale for BIONIK’s InMotion® robotic technology in the country, out of Curexo’s existing inventory.

• BIONIK Laboratories Announces Second Quarter Fiscal 2020 Financial Results

  11/15/2019

  BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced financial results for the second quarter of fiscal year 2020, ended September 30, 2019.

• BIONIK Laboratories Appoints Loren Wass as Chief Commercial Officer

  9/4/2019

  Industry veteran brings extensive experience driving the commercialization of robotic technologies within healthcare

• BIONIK Laboratories’ Fiscal Year 2020 Q1 Financial Results Feature 57% Increase in Sales

  8/13/2019

  Financial results for its first quarter of fiscal year 2020, ended June 30, 2019.

• BIONIK Laboratories’ Fiscal 2019 Financial Results Feature 229% Increase in Sales

  7/2/2019

  Reported sales of $3,246,038, an increase of 229% compared to the reported sales of $987,431 in the prior fiscal year.

• BIONIK Laboratories Third Quarter Fiscal 2019 Financial Results Feature 256% Increase in Sales

  2/11/2019

  BIONIK is a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home

• BIONIK Laboratories Launches Next-Generation InMotion ARM/HAND Robotic System to Improve Rehabilitation for Stroke Survivors

  1/23/2019

  Company introduces new technology at the American Physical Therapy Association Combined Sections Meeting January 23-26 in Washington, D.C.

• BIONIK Laboratories Announces Multi-Year Purchase Agreement and Ongoing Relationship with Kindred Hospital Rehabilitation Services for InMotion Arm™ Robotic Systems

  12/17/2018

  Multi-year commitment will place InMotion Arm™ Robots in existing and future Kindred Inpatient Rehabilitation Hospitals across the United States

• BIONIK Laboratories Second Quarter Fiscal 2019 Financial Results Feature 147% Increase in Revenues

  11/13/2018

  BIONIK Laboratories Corp. today announced financial results for the second quarter of fiscal year 2019, ended September 30, 2018.

• Bionik Laboratories Files Registration Statement for Proposed Follow-On Offering

  10/30/2018

  Bionik Laboratories Corp. announced today the filing of a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed underwritten follow-on public offering of shares of its common stock.